Holdings
Samsara Biocapital, LLC
As of Sep 30, 2026, Samsara Biocapital, LLC reported 26 positions worth US$1.05B. Largest: Scholar Rock Holding Corporation, Mineralys Therapeutics, Inc. and Septerna, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Scholar Rock Holding Corporation | 6.9M | US$333M | no change | Sep 30, 2026 |
| Mineralys Therapeutics, Inc. | 5.87M | US$148M | no change | Sep 30, 2026 |
| Septerna, Inc. | 3.07M | US$120M | −82,675 | Sep 30, 2026 |
| Alamar Biosciences, Inc. | 2.48M | US$84.5M | no change | Sep 30, 2026 |
| SpyGlass Pharma, Inc. | 2.11M | US$54.9M | no change | Sep 30, 2026 |
| Alumis Inc. | 7.24M | US$53.5M | +891K | Sep 30, 2026 |
| Neurogene Inc. | 1.87M | US$51.9M | +150K | Sep 30, 2026 |
| Kalaris Therapeutics, Inc. | 12.9M | US$37.2M | no change | Sep 30, 2026 |
| Inventiva SA | 6.31M | US$23.3M | no change | Sep 30, 2026 |
| Parabilis Medicines, Inc. | 556K | US$18M | no change | Sep 30, 2026 |